nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Topoisomerase Inhibitors—Irinotecan—colon cancer	0.51	1	CiPCiCtD
Idarubicin—breast cancer—colon cancer	0.326	1	CtDrD
Idarubicin—ABCC1—Irinotecan—colon cancer	0.0379	0.328	CbGbCtD
Idarubicin—ABCC1—Vincristine—colon cancer	0.0332	0.287	CbGbCtD
Idarubicin—ABCC1—Methotrexate—colon cancer	0.0201	0.174	CbGbCtD
Idarubicin—CYP2C9—Capecitabine—colon cancer	0.0153	0.132	CbGbCtD
Idarubicin—CYP2C9—Fluorouracil—colon cancer	0.00906	0.0784	CbGbCtD
Idarubicin—Neutropenic enterocolitis—Irinotecan—colon cancer	0.00346	0.074	CcSEcCtD
Idarubicin—Neutropenic colitis—Irinotecan—colon cancer	0.00216	0.0462	CcSEcCtD
Idarubicin—Palmar-plantar erythrodysaesthesia syndrome—Irinotecan—colon cancer	0.00216	0.0462	CcSEcCtD
Idarubicin—Palmar-plantar erythrodysaesthesia syndrome—Capecitabine—colon cancer	0.00145	0.0309	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Capecitabine—colon cancer	0.00102	0.0217	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Capecitabine—colon cancer	0.00102	0.0217	CcSEcCtD
Idarubicin—Cardiotoxicity—Fluorouracil—colon cancer	0.00101	0.0217	CcSEcCtD
Idarubicin—Recall phenomenon—Capecitabine—colon cancer	0.000962	0.0206	CcSEcCtD
Idarubicin—Leukaemia—Vincristine—colon cancer	0.000951	0.0203	CcSEcCtD
Idarubicin—Septic shock—Vincristine—colon cancer	0.000848	0.0181	CcSEcCtD
Idarubicin—Septic shock—Fluorouracil—colon cancer	0.000791	0.0169	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Methotrexate—colon cancer	0.000757	0.0162	CcSEcCtD
Idarubicin—Myocarditis—Capecitabine—colon cancer	0.000684	0.0146	CcSEcCtD
Idarubicin—Pericarditis—Fluorouracil—colon cancer	0.000552	0.0118	CcSEcCtD
Idarubicin—Septicemia—Methotrexate—colon cancer	0.000547	0.0117	CcSEcCtD
Idarubicin—Myelosuppression—Vincristine—colon cancer	0.000546	0.0117	CcSEcCtD
Idarubicin—Myelosuppression—Fluorouracil—colon cancer	0.000509	0.0109	CcSEcCtD
Idarubicin—TOP2A—Topotecan—Irinotecan—colon cancer	0.000497	0.404	CbGdCrCtD
Idarubicin—Cardiomyopathy—Fluorouracil—colon cancer	0.000467	0.00997	CcSEcCtD
Idarubicin—Leukaemia—Methotrexate—colon cancer	0.000461	0.00986	CcSEcCtD
Idarubicin—Mucosal inflammation—Irinotecan—colon cancer	0.00045	0.00963	CcSEcCtD
Idarubicin—Local reaction—Fluorouracil—colon cancer	0.000431	0.00922	CcSEcCtD
Idarubicin—Febrile neutropenia—Vincristine—colon cancer	0.000426	0.0091	CcSEcCtD
Idarubicin—Febrile neutropenia—Irinotecan—colon cancer	0.000415	0.00886	CcSEcCtD
Idarubicin—Sinus tachycardia—Capecitabine—colon cancer	0.000414	0.00886	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Fluorouracil—colon cancer	0.000402	0.00858	CcSEcCtD
Idarubicin—Febrile neutropenia—Fluorouracil—colon cancer	0.000397	0.00848	CcSEcCtD
Idarubicin—Embolism—Irinotecan—colon cancer	0.000388	0.0083	CcSEcCtD
Idarubicin—Bone marrow depression—Vincristine—colon cancer	0.000379	0.00811	CcSEcCtD
Idarubicin—Abdominal cramps—Vincristine—colon cancer	0.000379	0.00811	CcSEcCtD
Idarubicin—Abdominal cramps—Irinotecan—colon cancer	0.000369	0.00789	CcSEcCtD
Idarubicin—Lymphoma—Methotrexate—colon cancer	0.000356	0.0076	CcSEcCtD
Idarubicin—TOP2A—Vindesine—Vincristine—colon cancer	0.000355	0.289	CbGdCrCtD
Idarubicin—Cardiomyopathy—Capecitabine—colon cancer	0.000326	0.00697	CcSEcCtD
Idarubicin—Necrosis—Fluorouracil—colon cancer	0.000304	0.0065	CcSEcCtD
Idarubicin—Mucosal inflammation—Capecitabine—colon cancer	0.000301	0.00644	CcSEcCtD
Idarubicin—Extravasation—Vincristine—colon cancer	0.000293	0.00627	CcSEcCtD
Idarubicin—Pericarditis—Methotrexate—colon cancer	0.000287	0.00614	CcSEcCtD
Idarubicin—Extravasation—Irinotecan—colon cancer	0.000286	0.00611	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Capecitabine—colon cancer	0.000281	0.006	CcSEcCtD
Idarubicin—Febrile neutropenia—Capecitabine—colon cancer	0.000277	0.00593	CcSEcCtD
Idarubicin—Hyperuricaemia—Vincristine—colon cancer	0.000276	0.0059	CcSEcCtD
Idarubicin—Extravasation—Fluorouracil—colon cancer	0.000274	0.00585	CcSEcCtD
Idarubicin—Ulcer—Irinotecan—colon cancer	0.000264	0.00563	CcSEcCtD
Idarubicin—Blood uric acid increased—Vincristine—colon cancer	0.000261	0.00557	CcSEcCtD
Idarubicin—Embolism—Capecitabine—colon cancer	0.00026	0.00556	CcSEcCtD
Idarubicin—Ulcer—Fluorouracil—colon cancer	0.000253	0.0054	CcSEcCtD
Idarubicin—Bone marrow depression—Capecitabine—colon cancer	0.000247	0.00528	CcSEcCtD
Idarubicin—Colitis—Irinotecan—colon cancer	0.000239	0.00512	CcSEcCtD
Idarubicin—Neoplasm—Irinotecan—colon cancer	0.000225	0.00482	CcSEcCtD
Idarubicin—Mucosal inflammation—Methotrexate—colon cancer	0.000224	0.0048	CcSEcCtD
Idarubicin—TOP2A—Vinorelbine—Vincristine—colon cancer	0.000224	0.182	CbGdCrCtD
Idarubicin—Oesophagitis—Fluorouracil—colon cancer	0.000218	0.00466	CcSEcCtD
Idarubicin—Sepsis—Irinotecan—colon cancer	0.000216	0.00462	CcSEcCtD
Idarubicin—Thrombophlebitis—Irinotecan—colon cancer	0.000209	0.00447	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Methotrexate—colon cancer	0.000209	0.00446	CcSEcCtD
Idarubicin—Sepsis—Fluorouracil—colon cancer	0.000207	0.00443	CcSEcCtD
Idarubicin—Febrile neutropenia—Methotrexate—colon cancer	0.000207	0.00441	CcSEcCtD
Idarubicin—Thrombophlebitis—Fluorouracil—colon cancer	0.0002	0.00428	CcSEcCtD
Idarubicin—Embolism—Methotrexate—colon cancer	0.000194	0.00414	CcSEcCtD
Idarubicin—Bone marrow depression—Methotrexate—colon cancer	0.000184	0.00393	CcSEcCtD
Idarubicin—Burning sensation—Methotrexate—colon cancer	0.000179	0.00382	CcSEcCtD
Idarubicin—Ulcer—Capecitabine—colon cancer	0.000176	0.00377	CcSEcCtD
Idarubicin—Dehydration—Vincristine—colon cancer	0.000173	0.00369	CcSEcCtD
Idarubicin—Dehydration—Irinotecan—colon cancer	0.000168	0.0036	CcSEcCtD
Idarubicin—Colitis—Capecitabine—colon cancer	0.00016	0.00342	CcSEcCtD
Idarubicin—Necrosis—Methotrexate—colon cancer	0.000158	0.00338	CcSEcCtD
Idarubicin—TOP2A—Vinblastine—Vincristine—colon cancer	0.000154	0.125	CbGdCrCtD
Idarubicin—Pancytopenia—Vincristine—colon cancer	0.000153	0.00326	CcSEcCtD
Idarubicin—Oesophagitis—Capecitabine—colon cancer	0.000153	0.00326	CcSEcCtD
Idarubicin—Neoplasm—Capecitabine—colon cancer	0.000151	0.00322	CcSEcCtD
Idarubicin—Neutropenia—Vincristine—colon cancer	0.00015	0.00321	CcSEcCtD
Idarubicin—Neutropenia—Irinotecan—colon cancer	0.000146	0.00313	CcSEcCtD
Idarubicin—Sepsis—Capecitabine—colon cancer	0.000145	0.0031	CcSEcCtD
Idarubicin—Extravasation—Methotrexate—colon cancer	0.000142	0.00304	CcSEcCtD
Idarubicin—Pancytopenia—Fluorouracil—colon cancer	0.000142	0.00304	CcSEcCtD
Idarubicin—Acute coronary syndrome—Vincristine—colon cancer	0.000141	0.00302	CcSEcCtD
Idarubicin—Phlebitis—Capecitabine—colon cancer	0.000141	0.00301	CcSEcCtD
Idarubicin—Myocardial infarction—Vincristine—colon cancer	0.00014	0.003	CcSEcCtD
Idarubicin—Thrombophlebitis—Capecitabine—colon cancer	0.00014	0.00299	CcSEcCtD
Idarubicin—Stomatitis—Vincristine—colon cancer	0.00014	0.00298	CcSEcCtD
Idarubicin—Hepatic function abnormal—Capecitabine—colon cancer	0.000139	0.00296	CcSEcCtD
Idarubicin—Acute coronary syndrome—Irinotecan—colon cancer	0.000138	0.00294	CcSEcCtD
Idarubicin—Myocardial infarction—Irinotecan—colon cancer	0.000137	0.00292	CcSEcCtD
Idarubicin—Stomatitis—Irinotecan—colon cancer	0.000136	0.00291	CcSEcCtD
Idarubicin—Hyperuricaemia—Methotrexate—colon cancer	0.000134	0.00286	CcSEcCtD
Idarubicin—Acute coronary syndrome—Fluorouracil—colon cancer	0.000132	0.00281	CcSEcCtD
Idarubicin—Ulcer—Methotrexate—colon cancer	0.000131	0.00281	CcSEcCtD
Idarubicin—Myocardial infarction—Fluorouracil—colon cancer	0.000131	0.0028	CcSEcCtD
Idarubicin—Stomatitis—Fluorouracil—colon cancer	0.00013	0.00278	CcSEcCtD
Idarubicin—Hot flush—Capecitabine—colon cancer	0.00013	0.00277	CcSEcCtD
Idarubicin—Menopausal symptoms—Capecitabine—colon cancer	0.000128	0.00274	CcSEcCtD
Idarubicin—Atrial fibrillation—Capecitabine—colon cancer	0.000128	0.00273	CcSEcCtD
Idarubicin—Urinary tract disorder—Vincristine—colon cancer	0.000127	0.00271	CcSEcCtD
Idarubicin—Blood uric acid increased—Methotrexate—colon cancer	0.000127	0.0027	CcSEcCtD
Idarubicin—Urethral disorder—Vincristine—colon cancer	0.000126	0.00269	CcSEcCtD
Idarubicin—Haemoglobin—Irinotecan—colon cancer	0.000126	0.00269	CcSEcCtD
Idarubicin—Haemorrhage—Irinotecan—colon cancer	0.000125	0.00268	CcSEcCtD
Idarubicin—Haemoglobin—Fluorouracil—colon cancer	0.000121	0.00258	CcSEcCtD
Idarubicin—Haemorrhage—Fluorouracil—colon cancer	0.00012	0.00256	CcSEcCtD
Idarubicin—Angiopathy—Vincristine—colon cancer	0.000117	0.00249	CcSEcCtD
Idarubicin—Flushing—Irinotecan—colon cancer	0.000116	0.00248	CcSEcCtD
Idarubicin—Alopecia—Vincristine—colon cancer	0.000114	0.00243	CcSEcCtD
Idarubicin—Angiopathy—Irinotecan—colon cancer	0.000114	0.00243	CcSEcCtD
Idarubicin—Immune system disorder—Irinotecan—colon cancer	0.000113	0.00242	CcSEcCtD
Idarubicin—Daunorubicin—ABCB1—colon cancer	0.000113	0.552	CrCbGaD
Idarubicin—Dehydration—Capecitabine—colon cancer	0.000113	0.00241	CcSEcCtD
Idarubicin—Chills—Irinotecan—colon cancer	0.000112	0.0024	CcSEcCtD
Idarubicin—Neoplasm—Methotrexate—colon cancer	0.000112	0.0024	CcSEcCtD
Idarubicin—Arrhythmia—Irinotecan—colon cancer	0.000112	0.00239	CcSEcCtD
Idarubicin—Alopecia—Irinotecan—colon cancer	0.000111	0.00236	CcSEcCtD
Idarubicin—Sepsis—Methotrexate—colon cancer	0.000108	0.0023	CcSEcCtD
Idarubicin—Arrhythmia—Fluorouracil—colon cancer	0.000107	0.00229	CcSEcCtD
Idarubicin—Alopecia—Fluorouracil—colon cancer	0.000106	0.00226	CcSEcCtD
Idarubicin—Thrombophlebitis—Methotrexate—colon cancer	0.000104	0.00223	CcSEcCtD
Idarubicin—Anaemia—Vincristine—colon cancer	0.000103	0.00221	CcSEcCtD
Idarubicin—Anaemia—Irinotecan—colon cancer	0.000101	0.00215	CcSEcCtD
Idarubicin—Leukopenia—Vincristine—colon cancer	0.0001	0.00214	CcSEcCtD
Idarubicin—Pancytopenia—Capecitabine—colon cancer	9.94e-05	0.00213	CcSEcCtD
Idarubicin—Neutropenia—Capecitabine—colon cancer	9.79e-05	0.00209	CcSEcCtD
Idarubicin—Leukopenia—Irinotecan—colon cancer	9.76e-05	0.00209	CcSEcCtD
Idarubicin—Convulsion—Vincristine—colon cancer	9.7e-05	0.00207	CcSEcCtD
Idarubicin—Anaemia—Fluorouracil—colon cancer	9.65e-05	0.00206	CcSEcCtD
Idarubicin—Leukopenia—Fluorouracil—colon cancer	9.35e-05	0.002	CcSEcCtD
Idarubicin—Acute coronary syndrome—Capecitabine—colon cancer	9.2e-05	0.00197	CcSEcCtD
Idarubicin—Doxorubicin—ABCB1—colon cancer	9.16e-05	0.448	CrCbGaD
Idarubicin—Myocardial infarction—Capecitabine—colon cancer	9.15e-05	0.00196	CcSEcCtD
Idarubicin—Anaphylactic shock—Vincristine—colon cancer	9.14e-05	0.00195	CcSEcCtD
Idarubicin—Stomatitis—Capecitabine—colon cancer	9.1e-05	0.00194	CcSEcCtD
Idarubicin—Infection—Vincristine—colon cancer	9.08e-05	0.00194	CcSEcCtD
Idarubicin—Convulsion—Fluorouracil—colon cancer	9.05e-05	0.00193	CcSEcCtD
Idarubicin—Thrombocytopenia—Vincristine—colon cancer	8.94e-05	0.00191	CcSEcCtD
Idarubicin—Anaphylactic shock—Irinotecan—colon cancer	8.9e-05	0.0019	CcSEcCtD
Idarubicin—Chest pain—Fluorouracil—colon cancer	8.89e-05	0.0019	CcSEcCtD
Idarubicin—Infection—Irinotecan—colon cancer	8.84e-05	0.00189	CcSEcCtD
Idarubicin—Shock—Irinotecan—colon cancer	8.75e-05	0.00187	CcSEcCtD
Idarubicin—Thrombocytopenia—Irinotecan—colon cancer	8.71e-05	0.00186	CcSEcCtD
Idarubicin—Anorexia—Vincristine—colon cancer	8.71e-05	0.00186	CcSEcCtD
Idarubicin—Anaphylactic shock—Fluorouracil—colon cancer	8.52e-05	0.00182	CcSEcCtD
Idarubicin—Anorexia—Irinotecan—colon cancer	8.48e-05	0.00181	CcSEcCtD
Idarubicin—Infection—Fluorouracil—colon cancer	8.47e-05	0.00181	CcSEcCtD
Idarubicin—Haemoglobin—Capecitabine—colon cancer	8.42e-05	0.0018	CcSEcCtD
Idarubicin—Haemorrhage—Capecitabine—colon cancer	8.38e-05	0.00179	CcSEcCtD
Idarubicin—Thrombocytopenia—Fluorouracil—colon cancer	8.34e-05	0.00178	CcSEcCtD
Idarubicin—Urinary tract disorder—Capecitabine—colon cancer	8.28e-05	0.00177	CcSEcCtD
Idarubicin—Urethral disorder—Capecitabine—colon cancer	8.22e-05	0.00176	CcSEcCtD
Idarubicin—Anorexia—Fluorouracil—colon cancer	8.12e-05	0.00174	CcSEcCtD
Idarubicin—Decreased appetite—Vincristine—colon cancer	7.94e-05	0.0017	CcSEcCtD
Idarubicin—Flushing—Capecitabine—colon cancer	7.78e-05	0.00166	CcSEcCtD
Idarubicin—Decreased appetite—Irinotecan—colon cancer	7.73e-05	0.00165	CcSEcCtD
Idarubicin—Angiopathy—Capecitabine—colon cancer	7.6e-05	0.00163	CcSEcCtD
Idarubicin—Immune system disorder—Capecitabine—colon cancer	7.57e-05	0.00162	CcSEcCtD
Idarubicin—Chills—Capecitabine—colon cancer	7.52e-05	0.00161	CcSEcCtD
Idarubicin—Arrhythmia—Capecitabine—colon cancer	7.49e-05	0.0016	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vincristine—colon cancer	7.47e-05	0.0016	CcSEcCtD
Idarubicin—Decreased appetite—Fluorouracil—colon cancer	7.41e-05	0.00158	CcSEcCtD
Idarubicin—Alopecia—Capecitabine—colon cancer	7.41e-05	0.00158	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—colon cancer	7.4e-05	0.00158	CcSEcCtD
Idarubicin—Malnutrition—Capecitabine—colon cancer	7.3e-05	0.00156	CcSEcCtD
Idarubicin—Neutropenia—Methotrexate—colon cancer	7.29e-05	0.00156	CcSEcCtD
Idarubicin—Gastrointestinal pain—Irinotecan—colon cancer	7.28e-05	0.00155	CcSEcCtD
Idarubicin—Abdominal pain—Vincristine—colon cancer	7.22e-05	0.00154	CcSEcCtD
Idarubicin—Body temperature increased—Vincristine—colon cancer	7.22e-05	0.00154	CcSEcCtD
Idarubicin—Abdominal pain—Irinotecan—colon cancer	7.03e-05	0.0015	CcSEcCtD
Idarubicin—Body temperature increased—Irinotecan—colon cancer	7.03e-05	0.0015	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—colon cancer	6.77e-05	0.00145	CcSEcCtD
Idarubicin—Urticaria—Fluorouracil—colon cancer	6.77e-05	0.00145	CcSEcCtD
Idarubicin—Anaemia—Capecitabine—colon cancer	6.74e-05	0.00144	CcSEcCtD
Idarubicin—Body temperature increased—Fluorouracil—colon cancer	6.74e-05	0.00144	CcSEcCtD
Idarubicin—Hypersensitivity—Vincristine—colon cancer	6.73e-05	0.00144	CcSEcCtD
Idarubicin—Hypersensitivity—Irinotecan—colon cancer	6.56e-05	0.0014	CcSEcCtD
Idarubicin—Leukopenia—Capecitabine—colon cancer	6.53e-05	0.0014	CcSEcCtD
Idarubicin—Hypersensitivity—Fluorouracil—colon cancer	6.28e-05	0.00134	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—colon cancer	6.27e-05	0.00134	CcSEcCtD
Idarubicin—Diarrhoea—Vincristine—colon cancer	6.25e-05	0.00134	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—colon cancer	6.24e-05	0.00133	CcSEcCtD
Idarubicin—Chest pain—Capecitabine—colon cancer	6.21e-05	0.00133	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	6.17e-05	0.00132	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—colon cancer	6.16e-05	0.00132	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—colon cancer	6.12e-05	0.00131	CcSEcCtD
Idarubicin—Diarrhoea—Irinotecan—colon cancer	6.09e-05	0.0013	CcSEcCtD
Idarubicin—Infection—Capecitabine—colon cancer	5.92e-05	0.00126	CcSEcCtD
Idarubicin—Shock—Capecitabine—colon cancer	5.86e-05	0.00125	CcSEcCtD
Idarubicin—Diarrhoea—Fluorouracil—colon cancer	5.83e-05	0.00125	CcSEcCtD
Idarubicin—Thrombocytopenia—Capecitabine—colon cancer	5.83e-05	0.00125	CcSEcCtD
Idarubicin—Vomiting—Vincristine—colon cancer	5.81e-05	0.00124	CcSEcCtD
Idarubicin—Skin disorder—Capecitabine—colon cancer	5.78e-05	0.00124	CcSEcCtD
Idarubicin—Rash—Vincristine—colon cancer	5.76e-05	0.00123	CcSEcCtD
Idarubicin—Dermatitis—Vincristine—colon cancer	5.76e-05	0.00123	CcSEcCtD
Idarubicin—Headache—Vincristine—colon cancer	5.72e-05	0.00122	CcSEcCtD
Idarubicin—Anorexia—Capecitabine—colon cancer	5.68e-05	0.00121	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—colon cancer	5.66e-05	0.00121	CcSEcCtD
Idarubicin—Vomiting—Irinotecan—colon cancer	5.66e-05	0.00121	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—colon cancer	5.64e-05	0.0012	CcSEcCtD
Idarubicin—Rash—Irinotecan—colon cancer	5.61e-05	0.0012	CcSEcCtD
Idarubicin—Dermatitis—Irinotecan—colon cancer	5.6e-05	0.0012	CcSEcCtD
Idarubicin—Chills—Methotrexate—colon cancer	5.6e-05	0.0012	CcSEcCtD
Idarubicin—Headache—Irinotecan—colon cancer	5.57e-05	0.00119	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—colon cancer	5.51e-05	0.00118	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—colon cancer	5.43e-05	0.00116	CcSEcCtD
Idarubicin—Nausea—Vincristine—colon cancer	5.43e-05	0.00116	CcSEcCtD
Idarubicin—Vomiting—Fluorouracil—colon cancer	5.42e-05	0.00116	CcSEcCtD
Idarubicin—Rash—Fluorouracil—colon cancer	5.37e-05	0.00115	CcSEcCtD
Idarubicin—Dermatitis—Fluorouracil—colon cancer	5.37e-05	0.00115	CcSEcCtD
Idarubicin—Headache—Fluorouracil—colon cancer	5.34e-05	0.00114	CcSEcCtD
Idarubicin—Nausea—Irinotecan—colon cancer	5.28e-05	0.00113	CcSEcCtD
Idarubicin—Decreased appetite—Capecitabine—colon cancer	5.18e-05	0.00111	CcSEcCtD
Idarubicin—Nausea—Fluorouracil—colon cancer	5.06e-05	0.00108	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—colon cancer	5.02e-05	0.00107	CcSEcCtD
Idarubicin—Gastrointestinal pain—Capecitabine—colon cancer	4.87e-05	0.00104	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—colon cancer	4.86e-05	0.00104	CcSEcCtD
Idarubicin—Urticaria—Capecitabine—colon cancer	4.73e-05	0.00101	CcSEcCtD
Idarubicin—Body temperature increased—Capecitabine—colon cancer	4.71e-05	0.00101	CcSEcCtD
Idarubicin—Abdominal pain—Capecitabine—colon cancer	4.71e-05	0.00101	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—colon cancer	4.71e-05	0.00101	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—colon cancer	4.62e-05	0.000988	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	4.59e-05	0.000981	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—colon cancer	4.43e-05	0.000947	CcSEcCtD
Idarubicin—Infection—Methotrexate—colon cancer	4.4e-05	0.000941	CcSEcCtD
Idarubicin—Hypersensitivity—Capecitabine—colon cancer	4.39e-05	0.000938	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—colon cancer	4.34e-05	0.000928	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—colon cancer	4.31e-05	0.00092	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—colon cancer	4.23e-05	0.000903	CcSEcCtD
Idarubicin—Diarrhoea—Capecitabine—colon cancer	4.07e-05	0.000871	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—colon cancer	3.85e-05	0.000823	CcSEcCtD
Idarubicin—Vomiting—Capecitabine—colon cancer	3.79e-05	0.000809	CcSEcCtD
Idarubicin—Rash—Capecitabine—colon cancer	3.75e-05	0.000802	CcSEcCtD
Idarubicin—Dermatitis—Capecitabine—colon cancer	3.75e-05	0.000802	CcSEcCtD
Idarubicin—Headache—Capecitabine—colon cancer	3.73e-05	0.000797	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—colon cancer	3.62e-05	0.000775	CcSEcCtD
Idarubicin—Nausea—Capecitabine—colon cancer	3.54e-05	0.000756	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—colon cancer	3.52e-05	0.000753	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—colon cancer	3.5e-05	0.000749	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—colon cancer	3.5e-05	0.000749	CcSEcCtD
Idarubicin—Hypersensitivity—Methotrexate—colon cancer	3.27e-05	0.000698	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—colon cancer	3.03e-05	0.000648	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—colon cancer	2.82e-05	0.000602	CcSEcCtD
Idarubicin—Rash—Methotrexate—colon cancer	2.8e-05	0.000597	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—colon cancer	2.79e-05	0.000597	CcSEcCtD
Idarubicin—Headache—Methotrexate—colon cancer	2.78e-05	0.000593	CcSEcCtD
Idarubicin—Nausea—Methotrexate—colon cancer	2.63e-05	0.000563	CcSEcCtD
